Raymond James & Associates Sells 2,839 Shares of National Health Investors, Inc. (NYSE:NHI)

Raymond James & Associates lessened its stake in shares of National Health Investors, Inc. (NYSE:NHI) by 15.9% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 15,017 shares of the real estate investment trust’s stock after selling 2,839 shares during the period. Raymond James & Associates’ holdings in National Health Investors were worth $839,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of NHI. Sound Income Strategies LLC raised its position in National Health Investors by 33.5% during the 4th quarter. Sound Income Strategies LLC now owns 916 shares of the real estate investment trust’s stock valued at $51,000 after purchasing an additional 230 shares in the last quarter. EMC Capital Management increased its stake in shares of National Health Investors by 86.5% during the third quarter. EMC Capital Management now owns 3,357 shares of the real estate investment trust’s stock valued at $172,000 after buying an additional 1,557 shares during the period. AlphaMark Advisors LLC bought a new stake in shares of National Health Investors in the third quarter valued at about $249,000. Van ECK Associates Corp lifted its stake in National Health Investors by 4.3% in the third quarter. Van ECK Associates Corp now owns 4,889 shares of the real estate investment trust’s stock worth $251,000 after acquiring an additional 202 shares during the period. Finally, Inspire Investing LLC purchased a new stake in National Health Investors in the third quarter worth about $308,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Insider Buying and Selling at National Health Investors

In related news, Director Charlotte A. Swafford acquired 10,000 shares of the stock in a transaction dated Tuesday, February 27th. The stock was acquired at an average cost of $58.69 per share, for a total transaction of $586,900.00. Following the completion of the purchase, the director now owns 110,185 shares of the company’s stock, valued at approximately $6,466,757.65. The purchase was disclosed in a document filed with the SEC, which is available through this link. 8.21% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

NHI has been the subject of several recent research reports. Deutsche Bank Aktiengesellschaft started coverage on shares of National Health Investors in a report on Tuesday, January 30th. They issued a “buy” rating and a $69.00 price target for the company. StockNews.com lowered National Health Investors from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. BMO Capital Markets upgraded National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 price target on the stock in a report on Tuesday, March 12th. Wells Fargo & Company upgraded National Health Investors from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $55.00 to $63.00 in a research note on Monday, February 26th. Finally, Wedbush raised their price objective on National Health Investors from $64.00 to $66.00 and gave the company an “outperform” rating in a research report on Monday, March 18th. Five analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, National Health Investors presently has a consensus rating of “Hold” and a consensus price target of $60.50.

National Health Investors Price Performance

Shares of NHI stock opened at $62.35 on Tuesday. National Health Investors, Inc. has a fifty-two week low of $47.54 and a fifty-two week high of $62.93. The company has a debt-to-equity ratio of 0.90, a quick ratio of 10.27 and a current ratio of 10.27. The firm has a market capitalization of $2.71 billion, a price-to-earnings ratio of 19.92 and a beta of 0.95. The stock’s 50-day simple moving average is $58.97 and its 200-day simple moving average is $55.43.

National Health Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 3rd. Shareholders of record on Thursday, March 28th will be given a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 5.77%. The ex-dividend date is Wednesday, March 27th. National Health Investors’s dividend payout ratio is presently 115.02%.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.